🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Calcifying uremic arteriolopathy (or uremic calciphylaxis) is a rare diseas...
Status
Completed
Location
ECHO - Pole Santé Sud
Start Date
2021-05-20
Trial ID
NCT05633121
Treatments Being Tested
SUMMARY Age-related macular degeneration (AMD) is the leading cause of lat...
Status
Suspended
Location
Retinal Consultants of Arizona
Start Date
2007-01
Trial ID
NCT00460967
Treatments Being Tested
Peripheral arterial disease (PAD) is common in chronic hemodialysis patient...
Status
Unknown
Location
Grenoble University Hospital
Start Date
2022-06
Trial ID
NCT05373524
Treatments Being Tested
In this feasibility study, we aim to explore therapeutic Rheopheresis (Rheo...
Status
Unknown
Location
University Medical Center Göttingen
Start Date
2022-02-28
Trial ID
NCT05204784
Treatments Being Tested
AMD is a progressive disease of the retina which is nourished by a network ...
Status
Unknown
Location
Retina Vitreous Associates
Start Date
1999-08
Trial ID
NCT00078221
Treatments Being Tested
Purpose is to evaluate Rheopheresis for the treatment of patients with high...
Status
Completed
Location
University of Frankfurt Department of Ophthalmology
Start Date
1998-11
Trial ID
NCT00751361
Treatments Being Tested
The investigators propose to set up a prospective randomized controlled tri...
Status
Recruiting
Location
CHU d'Angers
Start Date
2023-03-07
Trial ID
NCT04654000
Treatments Being Tested
Peripheral arterial disease (PAD) with limb-threatening ischemia (PAD-LTI) ...
Status
Unknown
Location
Assistance Publique Hôpitaux de Marseille
Start Date
2021-01-14
Trial ID
NCT03975946
Treatments Being Tested
In this research rheohemapheresis will be used for the treatment of patient...
Status
Unknown
Location
Faculty Hospital
Start Date
2013-09
Trial ID
NCT01943396
Treatments Being Tested